https://vettapharma.com/pharmaceutical-news/sanofis-tolebrutinib-recommended-for-secondary-progressive-multiple-sclerosis-treatment-approval/ 2026-04-28T12:25:41Z VETTAPHARMA en Sanofi's Tolebrutinib Recommended for secondary progressive multiple sclerosis Treatment Approval 2026-04-28T11:57:09Z Blog https://vettapharma.com/pharmaceutical-news/eli-lilly-to-acquire-ajax-therapeutics-what-it-means-for-oncology/ 2026-04-28T11:50:49Z VETTAPHARMA en Eli Lilly to Acquire Ajax Therapeutics: What It Means for Oncology 2026-04-28T11:50:45Z Blog https://vettapharma.com/pharmaceutical-news/novartis-rhapsido-first-oral-therapy-for-chronic-urticaria/ 2026-04-28T10:45:15Z VETTAPHARMA en Novartis Rhapsido: First Oral Therapy for Chronic Urticaria 2026-04-28T10:45:11Z Blog https://vettapharma.com/pharmaceutical-news/gsks-bepirovirsen-for-chronic-hepatitis-b-fda-review-update/ 2026-04-28T10:01:51Z VETTAPHARMA en GSK's Bepirovirsen for Chronic Hepatitis B: FDA Review Update 2026-04-28T10:01:47Z Blog https://vettapharma.com/pharmaceutical-news/astrazenecas-breztri-aerosphere-approved-for-asthma-treatment/ 2026-04-28T09:51:21Z VETTAPHARMA en AstraZeneca's Breztri Aerosphere Approved for Asthma Treatment 2026-04-28T09:51:16Z Blog https://vettapharma.com/whats-new-in-artificial-intelligence/merck-google-cloud-partnership-accelerates-enterprise-ai-to-transform-drug-development-globally/ 2026-04-28T09:02:20Z VETTAPHARMA en Merck Partners with Google Gemini for AI-Driven Transformation 2026-04-28T09:01:41Z Blog